The Phoenix Mills Ltd. (PDF)
Trending Sector
Current IPOs
Closed IPOs
Listed IPOs
IPO Performers
CAGR Calculator
SIP Calculator
Retirement Planning Calculator
Adani Ports and SEZ
Balaxi Pharmaceuticals Ltd. Share Price
Balaxi Pharmaceuticals Ltd. (INR)70.63-2 (-2.8%) 
Exchange ScripsBSENSEBALAXIISININE618N01022
Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks
Trendline of performance -
Balaxi Pharmaceuticals Ltd. Performance
Market performance
Open price72.7
High75.08
Volumes67693
Prev Close70.63
Low68.1
Closing date2025-03-13
Historical performance
1 Year High151.45
3 Year High151.45
5 Year High216.04
1 Year Low50.42
3 Year Low50.42
5 Year Low12.87
Balaxi Pharmaceuticals Ltd. Fundamentals
Company Valuation
Market Cap (₹Cr)
397
Face Value (₹)
2
P/E Ratio
105.43
Dividend Yield
N/A
Balaxi Pharmaceuticals Ltd. Investment Returns
1 Year
-27.4%
3 Years
-15.4%
5 Years
305.9%
10 Years
N/A
Balaxi Pharmaceuticals Ltd. Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 71.5 | Bearish |
| 10-DMA | 63.52 | Bullish |
| 20-DMA | 59.84 | Bullish |
| 50-DMA | 66.74 | Bullish |
| 100-DMA | 74.19 | Bearish |
| 200-DMA | 92.71 | Bearish |
Shareholding Pattern
| Field | Dec-2024 | Sep-2024 | Jun-2024 | Mar-2024 | Dec-2023 |
|---|---|---|---|---|---|
| Promoters | 3 | 3 | 3 | 3 | 3 |
| Foreign Investors | --- | --- | --- | --- | --- |
| Domestic Investors | 3 | 3 | 3 | 3 | 3 |
| Public Investors | 8526 | 7860 | 6583 | 5203 | 5042 |
| Government | --- | --- | --- | --- | --- |
Balaxi Pharmaceuticals Ltd. Financials
Below figures are in Rs. Crores
| Particulars | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
| Other Income | 6 | 26 | 50 | 22 |
| Operating Profit | 452 | 601 | 558 | 449 |
| Interest | 28 | 14 | 8 | 3 |
| Depreciation | 21 | 18 | 5 | 3 |
| Profit Before Tax | 20 | 569 | 545 | 443 |
| Consolidated Net Profit | -73 | 517 | 482 | 372 |
| Adjusted EPS | -1 | 10 | 10 | 7 |
Balance Sheet
Below figures are in Rs. Crores
| Particulars | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
| Share Capital | 109 | 102 | 100 | 100 |
| Total Reserves | 1867 | 1624 | 1032 | 550 |
| Minority Interest | --- | --- | --- | --- |
| Total Non-Current Liabilities | 28 | 37 | --- | --- |
| Total Liabilities | 2583 | 2397 | 1765 | 997 |
| Capital Work in Progress | 23 | 28 | 6 | --- |
| Total Assets | 2583 | 2397 | 1765 | 997 |
Cash Flow
Below figures are in Rs. Crores
| Particulars | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
| Cash Flow from Operating Activities | 49 | 61 | 341 | --- |
| Cash Flow from Investing Activities | -10 | -106 | -284 | -60 |
| Cash Flow from Financing Activitie | 303 | 255 | -2 | 36 |
| Net Cash Inflow / Outflow | 341 | 210 | 55 | -23 |
14%
Negative
Neutral
Positive
- The stock has a PE ratio of 105.43.
- 3Y Stock Price CAGR of the stock is -4.9.
- The stock has a beta of 1.3.
- In the last financial year, the company had an EBITDA of ₹78 Million.
- The company generated revenue of ₹702 Million in the previous financial year.
Balaxi Pharmaceuticals Ltd.
70.63-2 (-2.8%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 744806.5
No. of Shares: 10545.2
Performance:-25.5%
P/L: ₹-255193.5
Top Gainers
| Symbol | Change% |
|---|---|
| HITECHCORP | 197.05(20%) |
| NACLIND | 92.38(16%) |
| GANDHITUBE | 728.2(15%) |
| FAIRCHEMOR | 1021.9(14%) |
| MTNL | 48.88(13%) |
Similar stocks
Announcing Stock of the Month!
